PATENT CLAIM ANALYSIS

Application Number: 15927357
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "093210"]

Abstract:
The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic cell.

Claim (Index 3):
The method of  claim 1 , wherein expression of the globin gene is increased.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.22222
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15172626', '14013250', '15847582', '14278903', '14013236']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7628664759894618
- 35 USC 102 Novelty (BERT): 0.5363558983351437
- Combined Prediction Score: 0.7402154182240299
- Mean Citation Score: 304.019042
- Max Citation Score: 376.76944
- Similarity Product: 207.590079908886

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test